Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan West

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BBA Advances|September 9, 2024
4-Phenyl-thiazole-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase do not alleviate orofacial inflammatory pain in female ratsDaniel Carr, Christopher Chin, Tiffany Chacon, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 20, 2026
Optimization of cortico-cortical spectral response analysis parameters for seizure onset zone localizationHelen E Brinyark, Rebekah Chatfield, Caila A Coyne, et al.
Pharmacology & Therapeutics|March 19, 2022
Enhancing autophagy in Alzheimer's disease through drug repositioningMehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonistsDavid Beattie, Andrew Brearley, Zarin Brown, et al.
Journal of Medicinal Chemistry|June 3, 2014
Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonistsLisa Rooney, Agnès Vidal, Anne-Marie D'Souza, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.
Research Square|June 12, 2026
Single-nucleus multiomic atlas of ALS primary motor cortex nominates neuroprotective WDR49-expressing astrocytesJohnathan Cooper-Knock, Sam Bonsall, Rodrigo Kazu, et al.
Nature Communications|August 27, 2025
The balance between B55α and Greatwall expression levels predicts sensitivity to Greatwall inhibition in cancer cellsRóbert Zach, Michael Annis, Sandra M Martin-Guerrero, et al.
Journal of Medicinal Chemistry|March 31, 2025
Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of RasCharles W Parry, Francesca Pellicano, Alexander W Schüttelkopf, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BBA Advances|September 9, 2024
4-Phenyl-thiazole-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase do not alleviate orofacial inflammatory pain in female ratsDaniel Carr, Christopher Chin, Tiffany Chacon, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 20, 2026
Optimization of cortico-cortical spectral response analysis parameters for seizure onset zone localizationHelen E Brinyark, Rebekah Chatfield, Caila A Coyne, et al.
Pharmacology & Therapeutics|March 19, 2022
Enhancing autophagy in Alzheimer's disease through drug repositioningMehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonistsDavid Beattie, Andrew Brearley, Zarin Brown, et al.
Journal of Medicinal Chemistry|June 3, 2014
Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonistsLisa Rooney, Agnès Vidal, Anne-Marie D'Souza, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.
Research Square|June 12, 2026
Single-nucleus multiomic atlas of ALS primary motor cortex nominates neuroprotective WDR49-expressing astrocytesJohnathan Cooper-Knock, Sam Bonsall, Rodrigo Kazu, et al.
Nature Communications|August 27, 2025
The balance between B55α and Greatwall expression levels predicts sensitivity to Greatwall inhibition in cancer cellsRóbert Zach, Michael Annis, Sandra M Martin-Guerrero, et al.
Journal of Medicinal Chemistry|March 31, 2025
Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of RasCharles W Parry, Francesca Pellicano, Alexander W Schüttelkopf, et al.
Pageof 2